🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our Valar Labs publication in European Urology validating Vesta Risk Stratify computational histology AI biomarkers to predict recurrence and progression in High Grade Ta Bladder Cancer. (1/5) Publication: authors.elsevier.com/c/1lFoD14kpm0h…

NO ASSOCIATION BETWEEN PREPROCEDURAL FASTING AND WITNESSED PULMONARY ASPIRATION A SYSTEMATIC REVIEW AND META-ANALYSIS I want to bring to everyone's attention the publication of an article we have been working on for some time. Ever been annoyed by having cases cancelled because

A novel west-African germline founder mutation in HOXB13 (p.X285Kext) increases risk of high-grade prostate cancer but also enhances sensitivity to hormonal therapy. Congrats to PCF-funded Mayuko Kanayama 👏 Neeraj Agarwal, MD, FASCO Prostate Cancer Foundation UroToday.com Ed Esplin, MD, PhD nature.com/articles/s4139…

🚨Epidemiology of High-risk Biochemical Recurrence After Primary #ProstateCancer Treatment🚨 🙍‍♂️🙍‍♂️17K population-based study 👉 Using BCR risk groups continues to show promise to personalize treatment intensity for future patients European Urology Oncology 🔗shorturl.at/LuvYZ

🚨Oncuria-Detect🚨 🔬Prof Charles J. Rosser, MD 💧Urine-based test 💡Negative predictive value 95% for detecting bladder cancer among pts w/ hematuria🩸regardless of stage/grade 📉 Could reduce the need for 66% of cystoscopies Open access🔗shorturl.at/IPVvu

Delighted to share our comprehensive review on #ProstateCancer, now out in CA: A Cancer Journal for Clinicians , the highest-impact STEM journal. Huge thanks to an amazing team ! Alison Tree 💙 Chris Parker Amar Kishan Vedang Murthy Nicholas van As The Royal Marsden NHS Foundation Trust The ICR Link: doi.org/10.3322/caac.7…

These crazy guys gave me a teaching award when really the night was all about them. Dr Peris Castañeda, MD and Dr Jeremiah Dallmer, congratulations on completing residency and moving on to your fellowships. You are two amazingly attended young surgeons.

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer Nature Communications rdcu.be/euijO Team science led by Kei Mizuno #BeltranLab Dana-Farber Lank Center for Genitourinary Oncology PCF Science

🚨Cannabis use & cancer screening🚨 🔥Cannabis users get less screening for #prostatecancer & #BreastCancer JCO Oncology Practice Adam Kibel Alexander P Cole UroToday.com Prostate Cancer Foundation Urology Times 🔗shorturl.at/Xtl4N

🤔Like treating stones? Department of Urology at Cedars-Sinai is looking for an endourologist to join our group

Excited to share that my PhD work is out in nature today! We engineered armoured CAR T cells to express therapeutic payloads only at the tumour site, to improve their safety and efficacy for the treatment of solid cancers. 1/14 nature.com/articles/s4158…

Great paper European Urology confirming safety of #activesurveillance for #prostatecancer out to 25 years in the Göteborg-1 trial. dx.doi.org/10.1016/j.euru…

🚨Detecting cribriform & IDC on MRI-guided prostate biopsy among pts w/ GG2-3 #prostatecancer🚨 👏First-author Raeven Grant (she/her) David Geffen School of Medicine at UCLA just out in ACS Journal Cancer 👉641 pts & 1186 GG2-3 tumors on MRI-guided biopsy 🔬Sensitivity for detecting cribriform, IDC, or either is

Endless gratitude for the incredible mentorship and guidance on this Adam B. Weiner, MD

💡 New in #EuropeanUrology: Are we extending life but neglecting quality of life for patients with #bladdercancer, #prostatecancer & #kidneycancer? Marie-Pier St-Laurent , Sarah P. Psutka MD MS, et al. call for better reporting of treatment burden & patient-reported outcomes in GU oncology. 🔗

👏Congrats Assistant Prof Adam B. Weiner, MD on their publication in ACS Journal Cancer on the sensitivity of MRI-guided prostate biopsy for detecting aggressive #prostatecancer histologies Cancer at Cedars-Sinai Cedars-Sinai Academic Medicine Department of Surgery at Cedars-Sinai Cedars-Sinai

I’m always reading a novel and luckily stumbled upon this last year The workaholic and personal sacrifice themes felt a bit too real reflecting on time during residency Highly recommend to my surgery colleagues

⚡️ On European Urology - While survival improves in GU cancers, treatment burden remains underreported. This review highlights a key gap: most trials neglect patient-reported outcomes like QoL & real-life impact. #BladderCancer #KidneyCancer sciencedirect.com/science/articl…

🚨What's in a name? Why differentiation between biochemical recurrence and metastatic #prostatecancer matters 👏 New review led by Anael Rizzo David Geffen School of Medicine at UCLA & Pratik Kanabur UCLA Urology 👉Differentiating BCR & metastatic risk groups is 🔑 to help personalize care for our patients